ArticleNature communications2026
Chiral chromophore engineered donor for constructing circularly polarized organic long-persistent luminescence exciplex.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Constructing chiral organic long-persistent luminescence materials has garnered considerable attention owing to their extraordinary ultralong emission duration but has thus far achieved limited success. Herein, we present a straightforward approach to develop chiral chromophore engineered donor for exploring chiral exciplex system, which exhibits a blue circularly polarized exciplex emission peaked at ~ 440 nm, as well as an ultralong yellow organic long-persistent luminescence from the triplet emission of chiral chromophore with emission peak at 540 nm and ultralong duration of 90 minutes. Particularly, the exciplex system achieves mirror-symmetric chiroptical signal with the dissymmetry factor of 7.8×10
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.